Clinical trial
Long-Term Sequelae of SARS-COV-2 Infection: Diabetes Mellitus
NCT05867017 is registered in ClinicalTrials.gov with The University of Texas Health Science Center at San Antonio as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-Term Sequelae of SARS-COV-2 Infection: Diabetes Mellitus
- Lead sponsor
- The University of Texas Health Science Center at San Antonio
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 10, 2023
- Completion date
- November 30, 2025
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19, diabete mellitus